Pricing Log in Create free account

Jazz Pharmaceuticals PLC (JAZZ) vs Bio-Techne Corp (TECH)

Jazz Pharmaceuticals PLC and Bio-Techne Corp are both Biotechnology companies. Jazz Pharmaceuticals PLC is the larger, with a market value of $14.6B against $11.4B — 1.3× the size. Bio-Techne Corp trades at the lower P/E: 62.2× against 62.6×. Jazz Pharmaceuticals PLC grew revenue faster over the last twelve months: 13.5% against −0.38%. Bio-Techne Corp has the higher net margin (15.0% vs 4.37%) and the higher return on invested capital (7.70% vs 3.86%). Across the 22 metrics below, Bio-Techne Corp leads on 13 and Jazz Pharmaceuticals PLC on 9.

Valuation

Metric JAZZ TECH Biotechnology median
P/E 62.55 62.15 10.26
P/S 3.12 9.33 9.18
P/B 3.51 5.38 2.05
Price to free cash flow 22.16 43.09 24.81
EV/EBITDA 15.24 32.32 0.65
EV/Sales 3.70 9.29 8.98
Earnings yield 1.60% 1.61% (34.89%)
Free cash flow yield 4.51% 2.32% (24.52%)

Profitability

Metric JAZZ TECH Biotechnology median
Gross margin 89.09% 65.77% 65.16%
Operating margin 9.03% 20.73% 0.00%
Net margin 4.37% 14.97% 0.00%
Free cash flow margin 14.08% 21.66% 0.00%
Return on equity 5.05% 9.03% (50.12%)
Return on assets 1.76% 7.07% (45.60%)
Return on invested capital 3.86% 7.70% 0.00%

Growth

Metric JAZZ TECH Biotechnology median
Revenue growth (TTM) 13.48% (0.38%) 6.26%
EPS growth (last fiscal year) (167.51%) 152.17% 29.88%
Revenue growth, 5-year CAGR 12.54% 5.47% 9.75%
Net income growth, 5-year CAGR 0.00% 5.31% 0.00%

Health

Metric JAZZ TECH Biotechnology median
Debt to equity 1.33 0.09 0.00
Current ratio 1.82 4.55 4.89
Net debt to EBITDA 10.96 (0.19) 1.01

Dividend

Metric JAZZ TECH Biotechnology median
Dividend yield — 0.44% 0.41%
Payout ratio — 0.28 —

Size

Metric JAZZ TECH Biotechnology median
Market cap 14.59b 11.41b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack